Canada markets closed

Rapid Dose Therapeutics Corp. (DOSE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.21000.0000 (0.00%)
At close: 10:06AM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 516.18M
Enterprise Value 317.67M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)84.48
Price/Book (mrq)N/A
Enterprise Value/Revenue 392.21
Enterprise Value/EBITDA 6-9.56

Trading Information

Stock Price History

Beta (5Y Monthly) 1.76
52-Week Change 3-32.26%
S&P500 52-Week Change 323.92%
52 Week High 30.5500
52 Week Low 30.1700
50-Day Moving Average 30.2201
200-Day Moving Average 30.3015

Share Statistics

Avg Vol (3 month) 399.98k
Avg Vol (10 day) 342.82k
Shares Outstanding 577.07M
Float 60.84M
% Held by Insiders 122.52%
% Held by Institutions 10.57%
Shares Short (Jan. 14, 2021) 4236.47k
Short Ratio (Jan. 14, 2021) 42.55
Short % of Float (Jan. 14, 2021) 4N/A
Short % of Shares Outstanding (Jan. 14, 2021) 40.31%
Shares Short (prior month Dec. 14, 2020) 441.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Feb. 15, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Feb. 28, 2020
Most Recent Quarter (mrq)Nov. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,177.84%

Management Effectiveness

Return on Assets (ttm)-30.83%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)191.58k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)37.34k
EBITDA -1.85M
Net Income Avi to Common (ttm)-2.42M
Diluted EPS (ttm)-0.0320
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)245.9k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.73M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.20
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)9.13k
Levered Free Cash Flow (ttm)1.92M